EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prorenin in Hepatic Stellate Cell Extracellular Vesicles Induces Platelet‐Dependent Thrombin Formation and Release of Profibrotic TGF ‐β

Rui Chen iD, Emily Huang iD, Xianfang Wu iD, Megan R McMullen iD, Xianjia Wang iD, Laura E Nagy iD, Ge Jin iD, Scott J Cameron iD, Thomas M McIntyre iD

The FASEB Journal · 31.10.2025 · 39 (20)

DOI: 10.1096/fj.202501902r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 15.10.2025. Verfasst von Rui Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular & Metabolic Sciences, Cleveland Clinic Research, Cleveland Clinic, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Hepatic Stellate Cells, Extracellular Vesicles, Thrombin, Blood Platelets. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HHS | NIH | National Institute on Alcohol Abuse and Alcoholism (NIAAA), HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), HHS | NIH | National Cancer Institute (NCI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dysregulated coagulation and platelet activation contribute to liver dysfunction and fibrosis, but mechanisms initiating these events are undefined. The hepatic stellate cell (HSC) agonist Concanavalin A (ConA) rapidly induces hepatitis, which progresses to hepatic fibrosis after serial exposure for 8 weeks. Extravascular platelets were intercalated throughout normal liver parenchyma, with ConA treatment activating resident platelets to degranulate and display P‐selectin. HSCs matured from activated human induced pluripotent stem cells or the human LX‐2 cell line released extracellular vesicles (EVs) that stimulated platelet aggregation, yet these particles lacked known platelet agonists, and this response differed from established behaviors. Enzymatic assays, biologic, chemical and aptamer inhibitors, immunohistochemistry, qPCR, REN siRNA, and western blotting elucidate a novel HSC‐EV mediated pathway to platelet activation. The aspartyl protease inhibitor pepstatin, or specific inhibitors Aliskiren and VTP23999 of the aspartyl protease renin suppressed HSC EV‐induced platelet activation, as did siRNA knockdown of prorenin. HSC maturation from mesenchymal cells increased prorenin transcripts, and HSC‐EV contained surface‐associated prorenin. Platelets expressed the prorenin receptor that overcomes prorenin auto‐inhibition, and HSC EV interacting with platelets generated renin peptidolytic activity. This interaction stimulated extrinsic and common coagulation cascades, formation of thrombin over time, activated platelet PAR‐1 thrombin receptors, and induced robust TGF‐β release. This TGF‐β stimulated the LX‐2 cell TGFbR1 receptor, Smad phosphorylation, and profibrotic protein expression. We identify hitherto undiscovered pathways by which platelet and HSC interaction stimulates thrombosis through prorenin activation and show intrahepatic platelets are positioned to stimulate fibrotic protein deposition in a model of hepatic fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatic Stellate CellsExtracellular VesiclesThrombinBlood PlateletsTransforming Growth Factor betaLiver CirrhosisHumansPlatelet ActivationAnimalsCell Line

Substanzen

ThrombinTransforming Growth Factor beta

Autor:innen und Institutionen

  • Department of Cardiovascular & Metabolic Sciences, Cleveland Clinic Research, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Inflammation and Immunity, Cleveland Clinic Research, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Infection Biology, Cleveland Clinic Research, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Molecular Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
  • Rammelkamp Center for Research, and Department of Medicine, Case Western Reserve University School of Medicine and MetroHealth System, Cleveland, Ohio, USA.
  • Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA.

ORCID-Profile: Rui Chen, Emily Huang, Xianfang Wu, Megan R McMullen, Xianjia Wang, Laura E Nagy, Ge Jin, Scott J Cameron, Thomas M McIntyre

Förderung

  • HHS | NIH | National Institute on Alcohol Abuse and Alcoholism (NIAAA)
  • HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
  • HHS | NIH | National Cancer Institute (NCI)
  • NIAAA NIH HHS
  • NIAID NIH HHS
  • NHLBI NIH HHS
  • NCI NIH HHS
  • HHS | National Institutes of Health (NIH)

Zitieren

APA

Chen, R., Huang, E., Wu, X., McMullen, M. R., Wang, X., Nagy, L. E., Jin, G., Cameron, S. J., & McIntyre, T. M. (2025). Prorenin in Hepatic Stellate Cell Extracellular Vesicles Induces Platelet‐Dependent Thrombin Formation and Release of Profibrotic TGF ‐β. The FASEB Journal, 39(20). https://doi.org/10.1096/fj.202501902r

Vancouver

Chen R, Huang E, Wu X, McMullen MR, Wang X, Nagy LE, et al. Prorenin in Hepatic Stellate Cell Extracellular Vesicles Induces Platelet‐Dependent Thrombin Formation and Release of Profibrotic TGF ‐β. The FASEB Journal. 2025;39(20). doi:10.1096/fj.202501902r

BibTeX
@article{Chen2025,
  author = {Chen, Rui and Huang, Emily and Wu, Xianfang and McMullen, Megan R and Wang, Xianjia and Nagy, Laura E and Jin, Ge and Cameron, Scott J and McIntyre, Thomas M},
  title = {Prorenin in Hepatic Stellate Cell Extracellular Vesicles Induces Platelet‐Dependent Thrombin Formation and Release of Profibrotic TGF ‐β},
  journal = {The FASEB Journal},
  year = {2025},
  volume = {39},
  number = {20},
  doi = {10.1096/fj.202501902r}
}
Kostenlos starten →